Partner relationships should start with the long-term in sight – just like a marriage, says Biogen.
GBSI has outlined an action plan after finding the frequency of irreproducible preclinical research exceeds 50% – costing the US nearly $28bn.
INC Research has expanded its Functional Service Provider (FSP) service offering to include investigator payment processing in response to increased transparency requirements.
Acticor Biotech has contracted QPS to manage a Phase I study of the company’s humanized Antibody Fragment, ACT017.
Data is a core competence for Big Pharma that should not be outsourced, according to an industry statistics expert.